ICOS CORPORATION

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 38217
 
  
 
C07D HETEROCYCLIC COMPOUNDS 28134
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 17150
 
  
 
C07K PEPTIDES 12124
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1085
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 891
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 891
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 7118
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9487772 Inhibitors of human phosphatidylinositol 3-kinase deltaNov 27, 13Nov 08, 16[C07D, C12N]
9149477 5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaMay 21, 14Oct 06, 15[A61K, C07D]
8993583 5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase deltaOct 08, 13Mar 31, 15[A61K, C07D]
8980901 5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase deltaOct 08, 13Mar 17, 15[A61K, C07D]
8779131 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaFeb 12, 13Jul 15, 14[C07D]
8653077 Inhibitors of human phosphatidylinositol 3-kinase deltaSep 28, 11Feb 18, 14[A61K, A01N, C07D, A61P]
8637533 Inhibitors of human phosphatidylinositol 3-kinase deltaFeb 17, 12Jan 28, 14[A61K, A01N, C07D]
8623881 Inhibitors of human phosphatidylinositol 3-kinase deltaOct 07, 09Jan 07, 14[A61K, A01N, C07D]
RE44638 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaDec 28, 12Dec 10, 13[A61K]
8586597 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaDec 27, 12Nov 19, 13[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0049,772 INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTAAbandonedSep 30, 16Feb 23, 17[A61K, C12N]
8455471 Compositions of CHK1 inhibitors and cyclodextrinExpiredOct 02, 07Jun 04, 13[A61K]
2012/0015,964 QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTAAbandonedJun 17, 11Jan 19, 12[A61K, C12N, C07D, A61P]
2011/0021,541 INHIBITORS OF HUMAN PHOSPHATIDYL-INOSITOL 3-KINASE DELTAAbandonedNov 12, 08Jan 27, 11[A61K, C07D, C12N, A61P]
2010/0256,167 QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTAAbandonedMar 25, 10Oct 07, 10[A61K, C07D, A61P]
2010/0216,820 THIENOPYRIMIDIONES FOR TREATMENT OF INFLAMMATORY DISORDERS AND CANCERSAbandonedNov 13, 07Aug 26, 10[A61K, C07D, A61P]
2010/0029,693 NOVEL PI3K DELTA INHIBITORS AND METHODS OF USE THEREOFAbandonedAug 10, 09Feb 04, 10[A61K, C07D]
2009/0312,548 MODIFIED PICTET-SPENGLER REACTION AND PRODUCTS PREPARED THEREFROMAbandonedJun 18, 09Dec 17, 09[C07D]
7608618 Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1ExpiredApr 27, 05Oct 27, 09[A61K, C07D, A61P]
7560462 Compounds useful for inhibiting CHK1ExpiredJul 01, 05Jul 14, 09[A61K, C07D, A61P]
2008/0318,974 Compounds Useful for Inhibiting Chk1AbandonedAug 18, 05Dec 25, 08[A61K, C07D, A61P]
2008/0293,105 Recombinant method for making multimeric proteinsAbandonedMay 14, 07Nov 27, 08[C12P]
2008/0234,271 Arylphenylamino- and Arylphenylether-Sulfide Derivatives, Useful For the Treatment of Inflammatory and Immune Diseases, and Pharmaceutical Compositions Containing ThemAbandonedApr 28, 05Sep 25, 08[A61K, C07D, A61P]
2007/0276,145 Method of Preparing a Ring Compound Having Two Adjacent Chiral CentersAbandonedApr 19, 04Nov 29, 07[C07D, C07C]
2007/0259,863 Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide DerivativesAbandonedApr 28, 05Nov 08, 07[C07D]
2007/0185,013 Use of chk1 inhibitors to control cell proliferationAbandonedSep 17, 04Aug 09, 07[A61K]
2007/0092,515 Methods of treating chronic pain using compositions that specifically bind cd11d (alpha-d) integrinAbandonedNov 08, 04Apr 26, 07[A61K]
2006/0280,739 Novel human beta-2 integrin alpha subunitAbandonedFeb 21, 06Dec 14, 06[A61K]
2006/0216,809 cGMP-binding, cGMP-specific phosphodiesterase materials and methodsAbandonedDec 21, 05Sep 28, 06[C07H, C12P, C12N]
2006/0205,020 Cell-cycle checkpoint genesAbandonedOct 14, 03Sep 14, 06[C07H, C12Q, C12P, G01N, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.